Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PLIANT THERAPEUTICS, INC. (PLRX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 379.9% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | -279.9% |
| Research and development | 1000.9% | 1024.2% | 158.3% | 83.0% | |
| General and administrative | 412.5% | 363.9% | 41.3% | 19.2% | -26.6% |
| Depreciation | 18.8% | 20.3% | 3.1% | 2.0% | -2.7% |
| EBIT | -1313.4% | -1288.1% | -99.6% | -2.2% | 126.6% |
| Pre-tax income | -1273.3% | -1284.5% | -99.3% | -1.1% | 124.0% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1273.3% | -1284.5% | -99.3% | -12.0% | 0.1% |
|